Document is current
Any future updates will be listed below
-
Authors
Ferrari, S.L.
Abrahamsen, B.
Napoli, N.
Akesson, K.
Chandran, M.
Eastell, R.
El-Hajj Fuleihan, G.
Josse, R.
Kendler, D.L.
Kraenzlin, M.
Suzuki, A.
Pierroz, D.D.
Schwartz, A.V.
Leslie, W.D.
,
Ferrari, S.L.
Abrahamsen, B.
Akesson, K.
Ardawi, M.S.M.
Chandran, M.
Cooper, C.
Eastell, R.
El-Hajj Fuleihan, G.
Josse, R.
Kendler, D.L.
Kraenzlin, M.
Leslie, W.D.
Mithal, A.
Napoli, N.
Suzuki, A.
Schwartz, A.V.
- License Information
-
More Information
Article History
Received: 7 June 2018
Accepted: 19 July 2018
First Online: 31 July 2018
Compliance with ethical standards
:
: S Ferrari has received research grants, honoraria, and/or consultancies from Amgen, UCB, MSD, Labatec, Agnovos. B Abrahamsen has received research contracts with Novartis and UCB with funds paid to the institution. D Kendler has received research grants, honoraria, and/or consultancies from Amgen, Eli Lilly, AstraZeneca, Pfizer. R Eastell has received research grants from Alexion, Amgen Inc., and Ultragenyx, and consulting fees from Immunodiagnostic Systems, GlaxoSmithKline, and Amgen Inc. A Suzuki has received research grants and/or honoraria from Astellas, Chugai, Daiichi-Sankyo, Kyowa-Hakko Kirin, MSD, Novo Nordisk, Ono, Pfizer, Taisho Toyama, Tanabe-Mitsubishi and Takeda. R Josse has received consultancy fees and speaker honoraria from Amgen, Lilly, Merck. K Akesson has received lecture fees or consultancies from MSD, UCB, Amgen, Eli Lilly and Sandoz. A Schwartz has received a research grant from Hologic and consulting fees from Amgen. N Napoli has received consulting fees from Lilly and Amgen. G El-Hajj Fulehain, M Chandran, DD Pierroz, M Kraenzlin have no disclosure.
